
Reaction to AstraZeneca/Oxford COVID-19 vaccine trial announcement
In response to the announcement today on the results of the AstraZeneca/Oxford COVID-19 vaccine trial, Oxfam’s Health policy Manager, Anna Marriott, said: “This is another
In response to the announcement today on the results of the AstraZeneca/Oxford COVID-19 vaccine trial, Oxfam’s Health policy Manager, Anna Marriott, said: “This is another
Other members of the G20 have exported more than US$17bn worth of arms to Saudi Arabia since it became involved in the conflict in Yemen
In response to the announcement today from the National Institutes of Health that early data shows Moderna’s COVID-19 vaccine is nearly 95 percent effective, Anna
Oxfam welcomes the G20 Finance Ministers’ discussions over the past few days around a new ‘common framework’ to tackle the debt crisis facing many developing
Over 1,000 health professionals from 66 countries have signed a letter urging the G20 to cancel the debt of developing countries, ahead of tomorrow’s extraordinary
OXFAM RESPONSE TO PFIZER INTERIM REPORT In response to Pfizer and BioNTech’s encouraging interim report about the effectiveness of their COVID-19 vaccine, Niko Lusiani, Senior Advisor
Oxfam congratulates President-elect Joe Biden in his hard-fought election victory to be the next President of the United States, and calls on him to deliver
More than 2 million people impacted as Super Typhoon Goni sweeps across the Philippines Oxfam is working with local partners and coordinating with local governments
Oxfam says the appointment of Hon Nanaia Mahuta as the new Minister for Foreign Affairs and Trade is welcomed and the aid agency looks forward
In reaction to the UN Security Council’s renewal of the mandate of the United Nations Mission for the Referendum in Western Sahara (MINURSU) 27 October, Oxfam